CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Empresa Charles River Laboratories International, Inc. Deutsche Boerse AG
Acciones
RV6
US1598641074
Biotecnología e investigación médica
|
Mercado cerrado -
Otros sitios de cotización
|
Después de cerrar 22:00:01 | |||
| 214,3 EUR | -0,37 % |
|
212,8 | -0,70 % |
Resumen de negocios
- servicios de descubrimiento y evaluación de la seguridad (63,4%): servicios de descubrimiento para la identificación, cribado y selección de compuestos principales para el desarrollo de nuevos fármacos candidatos, y pruebas in vivo e in vitro, incluidos estudios farmacocinéticos, bioanalíticos, metabólicos, toxicológicos y patológicos, para la evaluación de la seguridad de productos farmacéuticos, dispositivos médicos, productos zoosanitarios, productos químicos y agroquímicos y biocidas;
- desarrollo y venta de modelos de investigación y servicios relacionados (19,2%): ratones, ratas, modelos inmunodeficientes, conejos, cobayas, hámsters, etc. El grupo también ofrece células primarias y productos especializados (productos de bioconservación, medios de congelación para cultivos celulares, antígenos, péptidos, modelos de ratón humanizados, etc.) para el desarrollo y la fabricación de nuevas terapias celulares ;
- desarrollo de soluciones utilizadas en los procesos de fabricación de medicamentos (17,5%): productos y servicios para pruebas microbiológicas, pruebas in vitro, pruebas de endotoxinas, identificación microbiana, desarrollo, fabricación de vacunas aviares, etc. El grupo también ofrece servicios de fabricación por contrato para terapias celulares y génicas.
Las ventas netas se desglosan por fuente de ingresos entre ventas de servicios (83,3%) y ventas de productos (16,7%).
Las ventas netas se distribuyen geográficamente del siguiente modo: Estados Unidos (56,8%), Europa (26%), Canadá (11,8%), Asia/Pacífico (4,9%) y otros (0,4%).
Número de empleados: 21 100
Ventas por actividad
| USD en millones | 2022 | Peso | 2023 | Peso | Delta |
|---|---|---|---|---|---|
Discovery and Safety Assessment
63,3
%
| 2 447 | 61,6 % | 2 616 | 63,3 % | +6,88 % |
Research Models and Services
19,2
%
| 739 | 18,6 % | 792 | 19,2 % | +7,19 % |
Manufacturing Solutions
17,5
%
| 790 | 19,9 % | 721 | 17,5 % | -8,63 % |
Ventas por región
| USD en millones | 2022 | Peso | 2023 | Peso | Delta |
|---|---|---|---|---|---|
United States
56,8
%
| 2 342 | 58,9 % | 2 347 | 56,8 % | +0,23 % |
Europe
26,1
%
| 1 032 | 26,0 % | 1 077 | 26,1 % | +4,34 % |
Canada
11,8
%
| 399 | 10,0 % | 487 | 11,8 % | +22,14 % |
Asia Pacific
4,9
%
| 193 | 4,8 % | 201 | 4,9 % | +4,15 % |
Other
0,4
%
| 10 | 0,3 % | 17 | 0,4 % | +69,19 % |
Directores
| Directores | Puesto | Edad | Desde |
|---|---|---|---|
James Foster
CEO | Chief Executive Officer | 73 | 01/01/76 |
Flavia Pease
DFI | Director of Finance/CFO | 51 | 25/04/22 |
Birgit Girshick
COO | Chief Operating Officer | 54 | 01/04/89 |
Julie Frearson
CTO | Chief Tech/Sci/R&D Officer | - | 01/01/14 |
Mark Mintz
CTO | Chief Tech/Sci/R&D Officer | - | 01/02/21 |
| Compliance Officer | - | 01/02/01 | |
Matthew Daniel
CMP | Compliance Officer | - | 01/01/05 |
Todd Spencer
IRC | Investor Relations Contact | - | 01/06/18 |
Michael Knell
AUD | Comptroller/Controller/Auditor | 47 | 26/04/17 |
John C. Ho
PRN | Corporate Officer/Principal | 64 | 01/01/12 |
Administradores
| Administradores | Puesto | Edad | Desde |
|---|---|---|---|
C. Reese
BRD | Director/Board Member | 78 | 03/12/07 |
George Massaro
BRD | Director/Board Member | 76 | 01/01/03 |
Virginia Wilson
BRD | Director/Board Member | 68 | 01/10/19 |
Robert Bertolini
BRD | Director/Board Member | 61 | 25/01/11 |
Deborah Kochevar
BRD | Director/Board Member | 67 | 29/10/08 |
Richard Wallman
BRD | Director/Board Member | 72 | 24/01/11 |
James Foster
CEO | Chief Executive Officer | 73 | 01/01/76 |
Martin MacKay
BRD | Director/Board Member | 68 | 05/07/17 |
Nancy Andrews
BRD | Director/Board Member | 65 | 28/02/20 |
George Llado
BRD | Director/Board Member | 58 | 16/10/20 |
Clase de acciones
| Vote | Quantity | Flotante | Autocontrol | Total Float | |
|---|---|---|---|---|---|
| Acción A | 1 | 51 510 790 | 50 578 267 ( 98,19 %) | 0 | 98,19 % |
Información de la empresa
Charles River Laboratories International, Inc.
251 Ballardvale Street
01887, Wilmington
+781 222 6000
http://www.criver.com
Empresas del grupo
| Nombre | Categoría y sector |
|---|---|
Charles River Laboratories, Inc.
 Charles River Laboratories, Inc. Miscellaneous Commercial ServicesCommercial Services Charles River Laboratories, Inc. provides research models and laboratory animal support services. It offers quality research models and support services to the biomedical community. The company was founded in 1947 and is headquartered in Wilmington, MA. |
Miscellaneous Commercial Services
|
Celsis International Ltd.
 Celsis International Ltd. Medical SpecialtiesHealth Technology Celsis International Ltd. develops and supplies medical diagnostic products and laboratory services. The company was founded by Sir Christopher Evans in 1992 and is headquartered in Westminster, the United Kingdom. |
Medical Specialties
|
Charles River Discovery Research Services Finland Oy
 Charles River Discovery Research Services Finland Oy Miscellaneous Commercial ServicesCommercial Services Charles River Discovery Research Services Finland Oy provides non-clinical central nervous system services to the pharmaceutical and biotechnology industries. The company was founded in 1998 and is located in Kuopio, Finland. |
Miscellaneous Commercial Services
|
Charles River Laboratories Japan, Inc.
 Charles River Laboratories Japan, Inc. Miscellaneous Commercial ServicesCommercial Services Part of The Jackson Laboratory, Charles River Laboratories Japan, Inc. provides laboratory testing and research services. The private company is based in Yokohama, Japan. The Japanese company was founded in 1972. Charles River Laboratories Japan was acquired by The Jackson Laboratory from Charles River Laboratories International, Inc. on October 12, 2021 for $0.56 million. |
Miscellaneous Commercial Services
|
Charles River Laboratories Holdings Ltd.
 Charles River Laboratories Holdings Ltd. Financial ConglomeratesFinance Part of Charles River Laboratories International, Inc., Charles River Laboratories Holdings Ltd. is a British company that provides investment services. The private company is based in Margate, UK and was founded in 1999. |
Financial Conglomerates
|
Charles River UK Ltd.
 Charles River UK Ltd. Miscellaneous Commercial ServicesCommercial Services Founded in 1969, Charles River UK Ltd. is a subsidiary of Charles River Laboratories International, Inc. The private company is based in Margate, UK and engages in research and experimental development on biotechnology. |
Miscellaneous Commercial Services
|
Charles River Laboratories Preclinical Services Montreal ULC
 Charles River Laboratories Preclinical Services Montreal ULC Miscellaneous Commercial ServicesCommercial Services Part of Charles River Laboratories International, Inc., Charles River Laboratories Preclinical Services Montreal ULC is a private company based in Senneville, Canada. |
Miscellaneous Commercial Services
|
Charles River Nederland BV
 Charles River Nederland BV Miscellaneous Commercial ServicesCommercial Services Part of Charles River Laboratories International, Inc., Charles River Nederland BV is a private company based in Leiden, the Netherlands. |
Miscellaneous Commercial Services
|
Ballardvale CV
|
Sector
Ventas por actividad
Ventas por región
Revisiones del BPA
| Varia. 1 de ene. | Capi. | |
|---|---|---|
| -1,42 % | 41,35 mil M | |
| +42,15 % | 40,38 mil M | |
| +1,97 % | 39,05 mil M | |
| -14,19 % | 26,67 mil M | |
| +1,82 % | 24,07 mil M | |
| -24,55 % | 18,36 mil M | |
| +21,36 % | 11,6 mil M | |
| +8,20 % | 11,15 mil M | |
| -19,49 % | 9778,89 M |
- Bolsa de valores
- Acciones
- Acción CRL
- Acción RV6
- Empresa Charles River Laboratories International, Inc.
